1
|
Mahara A, Kojima K, Hirano Y, Yamaoka T. Arg-Glu-Asp-Val Peptide Immobilized on an Acellular Graft Surface Inhibits Platelet Adhesion and Fibrin Clot Deposition in a Peptide Density-Dependent Manner. ACS Biomater Sci Eng 2020; 6:2050-2061. [DOI: 10.1021/acsbiomaterials.0c00078] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Atsushi Mahara
- Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute, Kishibe Shim-machi, Suita, Osaka 564-8565, Japan
| | - Kentaro Kojima
- Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute, Kishibe Shim-machi, Suita, Osaka 564-8565, Japan
- Faculty of Chemistry, Materials and Bioengineering, Kansai University, 3-3-35 Yamatecho, Suita, Osaka 565-8680, Japan
| | - Yoshiaki Hirano
- Faculty of Chemistry, Materials and Bioengineering, Kansai University, 3-3-35 Yamatecho, Suita, Osaka 565-8680, Japan
| | - Tetsuji Yamaoka
- Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute, Kishibe Shim-machi, Suita, Osaka 564-8565, Japan
| |
Collapse
|
2
|
Lopera Higuita M, Griffiths LG. Small Diameter Xenogeneic Extracellular Matrix Scaffolds for Vascular Applications. TISSUE ENGINEERING PART B-REVIEWS 2019; 26:26-45. [PMID: 31663438 DOI: 10.1089/ten.teb.2019.0229] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Currently, despite the success of percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG) remains among the most commonly performed cardiac surgical procedures in the United States. Unfortunately, the use of autologous grafts in CABG presents a major clinical challenge as complications due to autologous vessel harvest and limited vessel availability pose a significant setback in the success rate of CABG surgeries. Acellular extracellular matrix (ECM) scaffolds derived from xenogeneic vascular tissues have the potential to overcome these challenges, as they offer unlimited availability and sufficient length to serve as "off-the-shelf" CABGs. Unfortunately, regardless of numerous efforts to produce a fully functional small diameter xenogeneic ECM scaffold, the combination of factors required to overcome all failure mechanisms in a single graft remains elusive. This article covers the major failure mechanisms of current xenogeneic small diameter vessel ECM scaffolds, and reviews the recent advances in the field to overcome these failure mechanisms and ultimately develop a small diameter ECM xenogeneic scaffold for CABG. Impact Statement Currently, the use of autologous vessel in coronary artery bypass graft (CABG) is common practice. However, the use of autologous tissue poses significant complications due to tissue harvest and limited availability. Developing an alternative vessel for use in CABG can potentially increase the success rate of CABG surgery by eliminating complications related to the use of autologous vessel. However, this development has been hindered by an array of failure mechanisms that currently have not been overcome. This article describes the currently identified failure mechanisms of small diameter vascular xenogeneic extracellular matrix scaffolds and reviews current research targeted to overcoming these failure mechanisms toward ensuring long-term graft patency.
Collapse
Affiliation(s)
| | - Leigh G Griffiths
- Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
| |
Collapse
|
3
|
Shi J, Chen S, Wang L, Zhang X, Gao J, Jiang L, Tang D, Zhang L, Midgley A, Kong D, Wang S. Rapid endothelialization and controlled smooth muscle regeneration by electrospun heparin‐loaded polycaprolactone/gelatin hybrid vascular grafts. J Biomed Mater Res B Appl Biomater 2018; 107:2040-2049. [DOI: 10.1002/jbm.b.34295] [Citation(s) in RCA: 39] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2018] [Revised: 11/12/2018] [Accepted: 11/23/2018] [Indexed: 12/13/2022]
Affiliation(s)
- Jie Shi
- Key Laboratory of Bioactive Materials for Ministry of Education, College of Life SciencesNankai University Tianjin 300071 China
| | - Siyuan Chen
- Key Laboratory of Bioactive Materials for Ministry of Education, College of Life SciencesNankai University Tianjin 300071 China
| | - Lina Wang
- Key Laboratory of Bioactive Materials for Ministry of Education, College of Life SciencesNankai University Tianjin 300071 China
| | - Xiangyun Zhang
- Key Laboratory of Bioactive Materials for Ministry of Education, College of Life SciencesNankai University Tianjin 300071 China
| | - Jingchen Gao
- Key Laboratory of Bioactive Materials for Ministry of Education, College of Life SciencesNankai University Tianjin 300071 China
| | - Li Jiang
- Key Laboratory of Bioactive Materials for Ministry of Education, College of Life SciencesNankai University Tianjin 300071 China
| | - Di Tang
- Key Laboratory of Bioactive Materials for Ministry of Education, College of Life SciencesNankai University Tianjin 300071 China
| | - Lin Zhang
- Key Laboratory of Bioactive Materials for Ministry of Education, College of Life SciencesNankai University Tianjin 300071 China
| | - Adam Midgley
- Key Laboratory of Bioactive Materials for Ministry of Education, College of Life SciencesNankai University Tianjin 300071 China
| | - Deling Kong
- Key Laboratory of Bioactive Materials for Ministry of Education, College of Life SciencesNankai University Tianjin 300071 China
| | - Shufang Wang
- Key Laboratory of Bioactive Materials for Ministry of Education, College of Life SciencesNankai University Tianjin 300071 China
| |
Collapse
|
4
|
Radke D, Jia W, Sharma D, Fena K, Wang G, Goldman J, Zhao F. Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development. Adv Healthc Mater 2018; 7:e1701461. [PMID: 29732735 PMCID: PMC6105365 DOI: 10.1002/adhm.201701461] [Citation(s) in RCA: 136] [Impact Index Per Article: 22.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2017] [Revised: 02/09/2018] [Indexed: 12/14/2022]
Abstract
Tissue engineered vascular grafts (TEVGs) are beginning to achieve clinical success and hold promise as a source of grafting material when donor grafts are unsuitable or unavailable. Significant technological advances have generated small-diameter TEVGs that are mechanically stable and promote functional remodeling by regenerating host cells. However, developing a biocompatible blood-contacting surface remains a major challenge. The TEVG luminal surface must avoid negative inflammatory responses and thrombogenesis immediately upon implantation and promote endothelialization. The surface has therefore become a primary focus for research and development efforts. The current state of TEVGs is herein reviewed with an emphasis on the blood-contacting surface. General vascular physiology and developmental challenges and strategies are briefly described, followed by an overview of the materials currently employed in TEVGs. The use of biodegradable materials and stem cells requires careful control of graft composition, degradation behavior, and cell recruitment ability to ensure that a physiologically relevant vessel structure is ultimately achieved. The establishment of a stable monolayer of endothelial cells and the quiescence of smooth muscle cells are critical to the maintenance of patency. Several strategies to modify blood-contacting surfaces to resist thrombosis and control cellular recruitment are reviewed, including coatings of biomimetic peptides and heparin.
Collapse
Affiliation(s)
- Daniel Radke
- Department of Biomedical Engineering, Michigan Technological University, 1400 Townsend Drive, Houghton, MI 49931, U.S
| | - Wenkai Jia
- Department of Biomedical Engineering, Michigan Technological University, 1400 Townsend Drive, Houghton, MI 49931, U.S
| | - Dhavan Sharma
- Department of Biomedical Engineering, Michigan Technological University, 1400 Townsend Drive, Houghton, MI 49931, U.S
| | - Kemin Fena
- Department of Biomedical Engineering, Michigan Technological University, 1400 Townsend Drive, Houghton, MI 49931, U.S
| | - Guifang Wang
- Department of Biomedical Engineering, Michigan Technological University, 1400 Townsend Drive, Houghton, MI 49931, U.S
| | - Jeremy Goldman
- Department of Biomedical Engineering, Michigan Technological University, 1400 Townsend Drive, Houghton, MI 49931, U.S
| | - Feng Zhao
- Department of Biomedical Engineering, Michigan Technological University, 1400 Townsend Drive, Houghton, MI 49931, U.S
| |
Collapse
|
5
|
Xu L, Guo Y, Huang Y, Xiong Y, Xu Y, Li X, Lu J, Wang L, Wang Y, Lu Y, Wang Z. Constructing heparin-modified pancreatic decellularized scaffold to improve its re-endothelialization. J Biomater Appl 2018; 32:1063-1070. [PMID: 29338566 DOI: 10.1177/0885328217752859] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Pancreas transplantation is considered as a promising therapeutic option with the potential to cure diabetes. However, efficacy of current clinical transplantation is limited by the donor organ. With regard to creating a functional pancreas-tissue equivalent for transplantation, vascularization remains a large obstacle. To enhance the angiogenic properties of pancreatic decellularized scaffold, surface modification of the vasculature was used to promote endothelialization efficiency. In this study, an endothelialized pancreatic decellularized scaffold was obtained through heparin modification under mild conditions. The immobilization of heparin was performed through 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide and N-Hydroxysuccinimide. The morphology, ultra-structure and porosity of the heparinized scaffold were characterized by toluidine blue staining, scanning electron microscope and infrared spectrum. The adhesion, proliferation and angiogenesis of human umbilical vein endothelial cells on heparin-pancreatic decellularized scaffold were also researched in vitro. In vivo transplantation was also performed to observe the location of human umbilical vein endothelial cells and the formation of new blood vessel, which exhibited significant differences with pancreatic decellularized scaffold group (p<0.05). These findings indicated that the endothelialized heparin-pancreatic decellularized scaffold may be used to solve the problem of blood supply and to support the function of insulin-secreting cells better after in vivo transplantation, and therefore, would be a potential candidate for pancreatic tissue engineering.
Collapse
Affiliation(s)
- Liancheng Xu
- 1 Research center of clinical medical, Affiliated Hospital of Nantong University, Nantong City, Jiangsu, PR China.,2 Department of General Surgery, Affiliated Hospital of Nantong University, Nantong City, Jiangsu, PR China
| | - Yibing Guo
- 1 Research center of clinical medical, Affiliated Hospital of Nantong University, Nantong City, Jiangsu, PR China
| | - Yan Huang
- 1 Research center of clinical medical, Affiliated Hospital of Nantong University, Nantong City, Jiangsu, PR China.,2 Department of General Surgery, Affiliated Hospital of Nantong University, Nantong City, Jiangsu, PR China
| | - Yicheng Xiong
- 3 Department of General Surgery , The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, PR China
| | - Yang Xu
- 1 Research center of clinical medical, Affiliated Hospital of Nantong University, Nantong City, Jiangsu, PR China.,2 Department of General Surgery, Affiliated Hospital of Nantong University, Nantong City, Jiangsu, PR China
| | - Xiaohong Li
- 1 Research center of clinical medical, Affiliated Hospital of Nantong University, Nantong City, Jiangsu, PR China
| | - Jingjing Lu
- 1 Research center of clinical medical, Affiliated Hospital of Nantong University, Nantong City, Jiangsu, PR China
| | - Lei Wang
- 2 Department of General Surgery, Affiliated Hospital of Nantong University, Nantong City, Jiangsu, PR China
| | - Yao Wang
- 2 Department of General Surgery, Affiliated Hospital of Nantong University, Nantong City, Jiangsu, PR China
| | - Yuhua Lu
- 1 Research center of clinical medical, Affiliated Hospital of Nantong University, Nantong City, Jiangsu, PR China.,2 Department of General Surgery, Affiliated Hospital of Nantong University, Nantong City, Jiangsu, PR China
| | - Zhiwei Wang
- 2 Department of General Surgery, Affiliated Hospital of Nantong University, Nantong City, Jiangsu, PR China
| |
Collapse
|
6
|
Improving in vivo outcomes of decellularized vascular grafts via incorporation of a novel extracellular matrix. Biomaterials 2017; 141:63-73. [PMID: 28667900 DOI: 10.1016/j.biomaterials.2017.06.025] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2017] [Revised: 06/19/2017] [Accepted: 06/19/2017] [Indexed: 12/30/2022]
Abstract
Each year, hundreds of thousands coronary bypass procedures are performed in the US, yet there currently exists no off-the-shelf alternative to autologous vessel transplant. In the present study, we investigated the use of mouse thrombospondin-2 knockout (TSP2 KO) cells, which secrete a non-thrombogenic and pro-migratory extracellular matrix (TSP2 KO ECM), to modify small diameter vascular grafts. To accomplish this, we first optimized the incorporation of TSP2 KO ECM on decellularized rat aortas. Because MMP levels are known to be elevated in TSP2 KO cell culture, it was necessary to probe the effect of the modification process on the graft's mechanical properties. However, no differences were found in suture retention, Young's modulus, or ultimate tensile strength between modified and unmodified grafts. Platelet studies were then performed to determine the time point at which the TSP2 KO ECM sufficiently reduced thrombogenicity. Finally, grafts modified by either TSP2 KO or WT cells or unmodified grafts, were implanted in an abdominal aortic interposition model in rats. After 4 weeks, grafts with incorporated TSP2 KO ECM showed improved endothelial and mural cell recruitment, and a decreased failure rate compared to control grafts. Therefore, our studies show that TSP2 KO ECM could enable the production of off-the-shelf vascular grafts while promoting reconstruction of native vessels.
Collapse
|